Concepedia

Lukas Schulig

LS

Statistics

Publications

12

Citations

245

H-Index

11

Active since

2018

Affiliations

Universität Greifswald(Current)

Universitätsmedizin Greifswald

Christian-Albrechts-Universität zu Kiel

Lukas Schulig is an author at Universität Greifswald specializing in medicinal chemistry, pharmacology, and pharmacy.

ORCID

Publications per year

2018–2024

12

Publications

12

Extensively Drug-Resistant Klebsiella pneumoniae Counteracts Fitness and Virulence Costs That Accompanied Ceftazidime-Avibactam Resistance Acquisition

Elias Eger, Michael Schwabe, Lukas Schulig et al. · Microbiology Spectrum · 2022 · 51 citations · Full text

, , +17

Sulfide Analogues of Flupirtine and Retigabine with Nanomolar K<sub>V</sub>7.2/K<sub>V</sub>7.3 Channel Opening Activity

Christian Bock, Abdrrahman Shemsu Surur, Kristin Beirow et al. · ChemMedChem · 2019 · 28 citations

, , +13

Flupirtine and retigabine as templates for ligand-based drug design of K<sub>V</sub>7.2/3 activators

Abdrrahman Shemsu Surur, Christian Bock, Kristin Beirow et al. · Organic & Biomolecular Chemistry · 2019 · 25 citations

, , +11

Tetrahydroindoles as Multipurpose Screening Compounds and Novel Sirtuin Inhibitors

Steffen Vojacek, Lukas Schulig, Nathalie Wössner et al. · ChemMedChem · 2019 · 20 citations

, , +14

Modifications of the Triaminoaryl Metabophore of Flupirtine and Retigabine Aimed at Avoiding Quinone Diimine Formation

Konrad W. Wurm, Frieda‐Marie Bartz, Lukas Schulig et al. · ACS Omega · 2022 · 20 citations · Full text

, , +10

1–5 of 12